23 evolution "https:" "https:" "https:" "https:" "https:" "https:" "Linköping university" research jobs at University of Lund
Sort by
Refine Your Search
-
Description of the workplace The Department of Immunotechnology conducts research ranging from advanced technology development to biomedical studies. The main research areas include sensitization
-
contribute to the area of protection of distributed AI. RESIST is in collaboration with Linköping University, Örebro University and the research institute RISE and is a multidisciplinary research center that
-
for Chemical Energy Conversion (MPI-CEC), under the direction of Prof. Serena De-Beer, focused on the development and application of advanced X-ray spectroscopic tools for under-standing processes in biological
-
for the development of the Ambient Pressure X-ray Photoelectron Spectroscopy Program at MAX IV. The beamlines provide a wide range of sample environments for in situ and operando XPS and XAS across four instruments and
-
to enable collaborative work between the two strategic research areas eSSENCE and NanoLund (https://www.essenceofescience.se/ and https://www.nano.lu.se/ ), which means that the postdoc will benefit from
-
Breast Cancer) is a so-called NEST(Novelty, Excellence, Synergy, and Teams) project lead by Karolinska Institutet and Linköping University together with Lund University and Uppsala University as partners
-
three areas of research have been identified for strategic development: materials research, integration of batteries with power electronics, and safe energy storage. On the educational side, the number
-
, graph theory and more to characterize biomolecular systems. The project is predominantly an applied project focusing on protein characterization; however, there is a possibility for method development
-
biology, analytical chemistry, evolution, and data science. The workplace offers access to state-of-the-art core facilities for advanced microscopy and cytometry, cell and molecular biology, extracellular
-
on the mechanisms underpinning the epigenetic control of the repetitive genome in stem cell models of early human development. The group was established in 2022 by Dr Christopher Douse and currently consists of seven